# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-109040
Filing Date
2025-08-14
Accepted
2025-08-14 17:02:38
Documents
77
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rkda-20250630.htm iXBRL | 10-Q | 2603635
2 | EX-31.1 | rkda-ex31_1.htm | EX-31.1 | 14652
3 | EX-31.2 | rkda-ex31_2.htm | EX-31.2 | 14721
4 | EX-32.1 | rkda-ex32_1.htm | EX-32.1 | 9423
5 | EX-32.2 | rkda-ex32_2.htm | EX-32.2 | 9380
| Complete submission text file | 0000950170-25-109040.txt |  | 11706673

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rkda-20250630.xsd | EX-101.SCH | 1836811
80 | EXTRACTED XBRL INSTANCE DOCUMENT | rkda-20250630_htm.xml | XML | 2328974

Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37383 | Film No.: 251220743
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)